BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND ARID2, ENSG00000189079, 196528, Q68CP9, p200, KIAA1557, FLJ30619, DKFZp779P0222, DKFZp686G052, BAF200
22 results:

  • 1. Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.
    Sun Y; Qin S; Wang S; Pang J; Ou Q; Liang W; Zhong H
    J Pathol Clin Res; 2024 May; 10(3):e12375. PubMed ID: 38661052
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Dysregulation of SWI/SNF Chromatin Remodelers in NSCLC: Its Influence on cancer Therapies including Immunotherapy.
    Shi Y; Shin DS
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371564
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mutational landscape of SWI/SNF complex genes reveal correlation to predictive biomarkers for immunotherapy sensitivity in lung adenocarcinoma patients.
    Xu H; Chen HC; Yang L; Yang G; Liang L; Yang Y; Tang H; Bao H; Wu X; Shao Y; An G; Wang Y
    ESMO Open; 2023 Jun; 8(3):101585. PubMed ID: 37327699
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinicopathologic, Genomic, and Immunophenotypic Landscape of ATM Mutations in Non-Small Cell lung cancer.
    Ricciuti B; Elkrief A; Alessi J; Wang X; Li Y; Gupta H; Muldoon DM; Bertram AA; Pecci F; Lamberti G; Di Federico A; Barrichello A; Vaz VR; Gandhi M; Lee E; Shapiro GI; Park H; Nishino M; Lindsay J; Felt KD; Sharma B; Cherniack AD; Rodig S; Gomez DR; Shaverdian N; Rakaee M; Bandlamudi C; Ladanyi M; Janne PA; Schoenfeld AJ; Sholl LM; Awad MM; Cheng ML
    Clin Cancer Res; 2023 Jul; 29(13):2540-2550. PubMed ID: 37097610
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Comprehensive profiling of EGFR mutation subtypes reveals genomic-clinical associations in non-small-cell lung cancer patients on first-generation EGFR inhibitors.
    Bai Y; Liu X; Zheng L; Wang S; Zhang J; Xiong S; Zhang P; Jiao Z; Zhao G; Zhou C; Pang J; Xu Y; Ou Q; Mao Y; Zhang L
    Neoplasia; 2023 Apr; 38():100888. PubMed ID: 36804751
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. USP2 Inhibits lung cancer Pathogenesis by Reducing arid2 Protein Degradation via Ubiquitination.
    Zhu L; Chen Z; Guo T; Chen W; Zhao L; Guo L; Pan X
    Biomed Res Int; 2022; 2022():1525216. PubMed ID: 36567903
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genomic and transcriptomic profiling reveals key molecules in metastatic potentials and organ-tropisms of hepatocellular carcinoma.
    Shi DM; Dong SS; Zhou HX; Song DQ; Wan JL; Wu WZ
    Cell Signal; 2023 Apr; 104():110565. PubMed ID: 36539000
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Pan-cancer analysis of ARID family members as novel biomarkers for immune checkpoint inhibitor therapy.
    Zhu Y; Yan C; Wang X; Xu Z; Lv J; Xu X; Yu W; Zhou M; Yue L
    Cancer Biol Ther; 2022 Dec; 23(1):104-111. PubMed ID: 35239432
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Concomitant novel ALK-SSH2, EML4-ALK and arid2-ALK, EML4-ALK double-fusion variants and confer sensitivity to crizotinib in two lung adenocarcinoma patients, respectively.
    Tao H; Liu Z; Mu J; Gai F; Huang Z; Shi L
    Diagn Pathol; 2022 Feb; 17(1):27. PubMed ID: 35144623
    [TBL] [Abstract] [Full Text] [Related]  

  • 10.
    Zhu G; Shi R; Li Y; Zhang Z; Xu S; Chen C; Cao P; Zhang H; Liu M; Pan Z; Liu H; Chen J
    Front Immunol; 2021; 12():670040. PubMed ID: 34512623
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genetic Mutation Analysis in Small Cell lung cancer by a Novel NGS-Based Targeted Resequencing Gene Panel and Relation with Clinical Features.
    Jin W; Lei Z; Xu S; Fachen Z; Yixiang Z; Shilei Z; Tao G; Zhe S; Fengzhou L; Su WH; Chundong G
    Biomed Res Int; 2021; 2021():3609028. PubMed ID: 33880365
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. SMARCA4 and Other SWItch/Sucrose NonFermentable Family Genomic Alterations in NSCLC: Clinicopathologic Characteristics and Outcomes to Immune Checkpoint Inhibition.
    Alessi JV; Ricciuti B; Spurr LF; Gupta H; Li YY; Glass C; Nishino M; Cherniack AD; Lindsay J; Sharma B; Felt KD; Rodig SJ; Cheng ML; Sholl LM; Awad MM
    J Thorac Oncol; 2021 Jul; 16(7):1176-1187. PubMed ID: 33845210
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. arid2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer.
    Moreno T; Monterde B; González-Silva L; Betancor-Fernández I; Revilla C; Agraz-Doblas A; Freire J; Isidro P; Quevedo L; Blanco R; Montes-Moreno S; Cereceda L; Astudillo A; Casar B; Crespo P; Morales Torres C; Scaffidi P; Gómez-Román J; Salido E; Varela I
    Oncogene; 2021 Apr; 40(16):2923-2935. PubMed ID: 33742126
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Mutation profile of non-small cell lung cancer revealed by next generation sequencing.
    Chang YS; Tu SJ; Chen YC; Liu TY; Lee YT; Yen JC; Fang HY; Chang JG
    Respir Res; 2021 Jan; 22(1):3. PubMed ID: 33407425
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Chromatin remodeling factor arid2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis.
    Jiang H; Cao HJ; Ma N; Bao WD; Wang JJ; Chen TW; Zhang EB; Yuan YM; Ni QZ; Zhang FK; Ding XF; Zheng QW; Wang YK; Zhu M; Wang X; Feng J; Zhang XL; Cheng SQ; Ma DJ; Qiu L; Li JJ; Xie D
    Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4770-4780. PubMed ID: 32071245
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Multi-omic molecular comparison of primary versus metastatic pancreatic tumours.
    Brar G; Blais EM; Joseph Bender R; Brody JR; Sohal D; Madhavan S; Picozzi VJ; Hendifar AE; Chung VM; Halverson D; Mikhail S; Matrisian LM; Rahib L; Petricoin E; Pishvaian MJ
    Br J Cancer; 2019 Jul; 121(3):264-270. PubMed ID: 31292535
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prognosis related miRNAs, DNA methylation, and epigenetic interactions in lung adenocarcinoma.
    Liu H; Zhao H
    Neoplasma; 2019 May; 66(3):487-493. PubMed ID: 30868896
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. K-ras mutation promotes ionizing radiation-induced invasion and migration of lung cancer in part via the Cathepsin L/CUX1 pathway.
    Wang L; Zhao Y; Xiong Y; Wang W; Fei Y; Tan C; Liang Z
    Exp Cell Res; 2018 Jan; 362(2):424-435. PubMed ID: 29246726
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Concordant clear cell "mesonephric" carcinoma of the bladder and lung adenocarcinoma with clear cell features - multiple primaries versus metastatic neoplasms: a case report.
    Jassim SH; Khiyami A; Nguyen JK; Ganesan S; Tomashefski J; Sawady J
    J Med Case Rep; 2017 May; 11(1):133. PubMed ID: 28494807
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Loss of function of SWI/SNF chromatin remodeling genes leads to genome instability of human lung cancer.
    Huang HT; Chen SM; Pan LB; Yao J; Ma HT
    Oncol Rep; 2015 Jan; 33(1):283-91. PubMed ID: 25370573
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.